HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 56 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,916,506 | +21.0% | 2,302,000 | +21.0% | 0.00% | 0.0% |
| Q2 2023 | $1,583,415 | -1.3% | 1,902,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,603,576 | -19.3% | 1,902,000 | -10.4% | 0.00% | 0.0% |
| Q4 2022 | $1,987,659 | -19.2% | 2,123,000 | -26.0% | 0.00% | 0.0% |
| Q3 2022 | $2,461,000 | +81.0% | 2,870,000 | +92.4% | 0.00% | 0.0% |
| Q2 2022 | $1,360,000 | – | 1,492,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 59,699,359 | $50,184,506 | 4.08% |
| CAMDEN ASSET MANAGEMENT L P /CA | 77,523,000 | $64,387,999 | 2.23% |
| Penn Mutual Asset Management | 1,555,000 | $1,292,816 | 1.17% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 52,037,000 | $43,220,184 | 0.90% |
| ZAZOVE ASSOCIATES LLC | 9,418,000 | $7,850 | 0.72% |
| LAFFER TENGLER INVESTMENTS, INC. | 2,586 | $2,159,136 | 0.57% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,615,000 | $7,157,514 | 0.56% |
| LINDEN ADVISORS LP | 57,430,000 | $47,848,953 | 0.50% |
| SSI INVESTMENT MANAGEMENT LLC | 6,295,000 | $5,228,415 | 0.37% |
| Sonora Investment Management Group, LLC | 3,635,000 | $3,054,958 | 0.26% |